Black Rock Inc. Evotec Se Transaction History
Black Rock Inc.
- $4.23 Trillion
- Q1 2024
A detailed history of Black Rock Inc. transactions in Evotec Se stock. As of the latest transaction made, Black Rock Inc. holds 37,600 shares of EVO stock, worth $177,472. This represents 0.0% of its overall portfolio holdings.
Number of Shares
37,600
Previous 12,178
208.75%
Holding current value
$177,472
Previous $142,000
107.04%
% of portfolio
0.0%
Previous 0.0%
Shares
9 transactions
Others Institutions Holding EVO
# of Institutions
21Shares Held
347KCall Options Held
0Put Options Held
0-
Morgan Stanley New York, NY87.6KShares$413,5000.0% of portfolio
-
Israel Englander Millennium Management LLC | New York, Ny82.8KShares$390,8860.0% of portfolio
-
Dcf Advisers, LLC Greenwich, CT47.8KShares$225,6010.19% of portfolio
-
Optiver Holding B.V. Amsterdam, P741.5KShares$195,9130.01% of portfolio
-
Cetera Investment Advisers Schaumburg, IL24.5KShares$115,8420.0% of portfolio
About Evotec SE
- Ticker EVO
- Exchange OTC
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 353,904,992
- Market Cap $1.67B
- Description
- Evotec SE operates as drug discovery and development partner for the pharmaceutical and biotechnology industry worldwide. The company is developing pharmaceutical products in various therapeutic areas, such as diabetes and complications of diabetes, fibrosis, infectious diseases, CNS diseases, oncology, pain and inflammation, immunology, rare di...